S&P 5007,691▲ 0.41%Nasdaq26,431▲ 1.11%Dow Jones51,966▼ 0.07%Nasdaq 10029,529▲ 1.17%VIX18.44▼ 7.75%US Dollar101.97▲ 0.13%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
Home › WUXI06 › Research report
← WUXI06 page
XStocksXray
Market X-Ray report · 19 October 2026

WuXi Biologics (Cayman) Inc. (WUXI06)

Thailand Exchange · Thailand · prices in THB · close of 19 Oct 2026

Key indicators

Last closeTHB 5.200
52-week range3.020 – 6.250
Return, 1 month / 3 months−2.8% / +26.8%
Return, 1 year / 3 years– / –
TrendAbove 200-day, below 50-day
RSI (14)41
Volatility (1 year)51.8%
Worst drawdown (1 year)-25.1%
Average daily value traded0.49M THB
Dividend yield–

Market X-Ray price-based

65/ 100 · Medium confidence · ahead of 74% of stocks on this exchange
Trend77
Momentum92
Stability (higher is calmer)41
Liquidity39
Income–

Five-year price chart navy: price · brown: 200-day average

2.913.794.685.566.442025-102026-012026-042026-072026-10

About the company

WuXi Biologics is a contract research, development and manufacturing organisation focused on biologic medicines. The company helps pharmaceutical and biotechnology customers discover, develop and produce antibody-based and other biologic drugs, offering services that span early research through clinical and commercial manufacturing. It is based in China and works with clients around the world, supporting their biologic programmes with process development, testing and production capacity.

The shares are listed on the Thailand Exchange in Thailand under the code WUXI06, and the price on this page is in Thai baht (THB). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

WuXi Biologics (Cayman) Inc. (WUXI06) trades on the Thailand Exchange in Thailand. It last closed at THB 5.200 on 19 October 2026.

Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 347 of 1,348 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
WuXi Biologics (Cayman) Inc. (WUXI06)

The five lenses in numbers each metric is ranked against the other stocks on Thailand Exchange

Lens and metricValueScoreReading
Trend77 · StrongTrading above its long-term averages and near its highs.
Above 200-day average26.2%
From 52-week high-16.8%
Momentum92 · StrongRising faster than most stocks on this exchange.
3-month return26.8%
6-month return44.4%
12-month return, skipping the last month–
Stability (higher is calmer)41 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)51.8%
Worst drawdown, 1 year (smaller is calmer)-25.1%
Liquidity39 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.49M THB
Zero-volume days5.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.
  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week−11.1%
1 month−2.8%
3 months+26.8%
6 months+44.4%
1 year–
3 years–
5 years–

Signals

50-day / 200-day average5.384 / 4.121
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.250

Technical summary

DailyNeutral7 bullish · 1 neutral · 7 bearish
WeeklyBullish5 bullish · 1 neutral · 2 bearish
MonthlyStrongly bullish2 bullish · 0 neutral · 0 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Thailand Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 20 Oct 2026